HomeThe enzymeTechnologyIngredientsStudiesAbout

A review of MMP13 as a target for protecting cartilage

MMP13 biologyReview2021

This 2021 review describes MMP13 as the primary matrix metalloproteinase involved in cartilage breakdown, because of its particular ability to cleave type II collagen. It covers how MMP13 activity is controlled, including at the epigenetic level, and the strategies used against it, and notes that no current intervention restores degraded cartilage.

Evidence typeReview
Who or what was studiedNot stated in the abstract
Dose and durationNot stated in the abstract

What they did

This is a review of published work, not a new experiment. The authors brought together research on how MMP13 is involved in the start and the progression of cartilage breakdown, how its activity is controlled at the molecular and epigenetic levels (switches that change how a gene is read without changing the gene itself), and the strategies researchers have used to block it.

What they found

The review states that MMP13 is the primary MMP involved in cartilage degradation, through its particular ability to cleave type II collagen, and that this makes it an attractive target. It also notes that the detailed molecular mechanisms of how the disease starts and progresses remain unclear, and that there are currently no interventions available to restore degraded cartilage. Its stated aim is to identify MMP13 as a target for inhibitor development.

What it can't tell us

As a review, it adds no new data, and its conclusions depend on the studies it selected. The abstract is short and does not list which inhibitors were covered or how they performed. It does not tell us whether blocking MMP13 helps people, only why researchers think it is worth trying.

Why it matters

It is a recent, freely available summary of why MMP13 matters: it is the enzyme singled out for cutting type II collagen, the collagen that holds cartilage together. Its statement that nothing yet restores lost cartilage explains why so much of the research focuses on keeping the collagen that is still there.

The paper

  1. Hu Q, Ecker M. Overview of MMP-13 as a Promising Target for the Treatment of Osteoarthritis. Int J Mol Sci 2021.

Read next

Last reviewed 3 November 2026Every study cited here is indexed on PubMed. How we read the evidence